Skip to content
Home/Companies/Biotech/Boundless Bio
BB

Boundless Bio

Biotech·United States·Exited 2024·Held 1yr

Boundless Bio is a biotech company, headquartered in United States.

Entry
2023
Hold
1yr
Exit
2024
Est. EV
–

Who owns Boundless Bio?

Boundless Bio was owned by Leaps by Bayer through Leaps by Bayer (2015 vintage) from 2023 to 2024, exited via IPO.

Hand-verified · updated 2026-07-03

Leaps by Bayer
Investor
Leaps by Bayer
Leaps by Bayer · 2015 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2024

More from Leaps by Bayer

Other portfolio companies in the same fund.

Celea Therapeutics
Active
BiotechUnited States· 2026
Leaf Agriculture
Active
ClimateTechUnited States· 2026
SonoThera
Active
BiotechUnited States· 2026
Souffle Therapeutics
Active
BiotechUnited States· 2025
WellTheory
Active
HealthTechUnited States· 2025
Capstan Therapeutics
Exited 2025
BiotechUnited States· 2022
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings